Notifications for Medical and Pharmaceutical Professionals
Documents
2022
- 4 August 2022: Announcement by the Federal Ministry of Health and the Paul-Ehrlich-Institut (dated 29 July 2022): Non-interventional studies with authorised vaccines
- 11 July 2022: Information for Manufacturers and Distributors: COVID-19 Antigen Tests
- 31 March 2022: Risk Evaluation for Potential Nitrosamine Impurities for National Authorised Medicines for Human Use in the Competence of the Paul-Ehrlich-Institut (Updated March 2022)
- 10 March 2022: Information for Manufacturers and Distributors - COVID-19 Antigen Tests
- 28 February 2022 PEI-C Rebuild – Electronic Transmission of the Batch Release Documents for further Product Groups
- 03 February 2022: On the Statement of DG SANTE on Article 152(2) of Regulation 2019/6 on veterinary medicinal products (German only)
- 28 January 2022: Information and important notes on the use of the Union Product Database (UPD), the central database for information on all authorised veterinary medicinal products and their availability in the European Union (EU) (German only)
- 13 January 2022: Information for Healthcare Professionals - Casirivimab/Imdevimab (Ronapreve) 120 mg/ml Solution for Injection/Infusion: Considerably reduced neutralisation of the Omicron variant fulllength spike protein from the casirivimab/imdevimab antibody combination
2021
- 13 December 2021: Information for Medical Doctors - Possibility of treating hospitalised COVID-19 patients under low-flow oxygen treatment with casirivimab/imdevimab
- 10 December 2021: Use of Comirnaty for 5- to 11-Year-Old Children - Important Information for Medical Doctors
- 26 July 2021: The Paul-Ehrlich-Institut asks for attention to the information provided by of the Schleswig-Holstein Office for Social Services (Landesamt für soziale Dienste Schleswig-Holstein, LAsD-SH) on self-manufacture and the prerequisites for a licence-free manufacture of medicines by medical doctors, including vaccines against SARS-CoV-2 (German only)
- 31 May 2021: Information for Medical Doctors - SARS-CoV-2 Neutralising Monoclonal Antibodies
- 17 May 2021: Notes on Marketing Authorisation Procedures During the COVID-19 Pandemic
- 11 May 2021 PEI-C Rebuild – Electronic Transmission of the Batch Release Documents
- 19 March 2021: Information for Medical Doctors - COVID-19 Vaccine AstraZeneca
- 01 February 2021: Public Consultation: Draft Joint Announcement by BfArM and Paul-Ehrlich-Institut for the Follow-up of Spontaneous Reports of Suspected Cases of Adverse Effects pursuant to Section 63c AMG
2020
- 23 December 2020: Recommendation on Corona Vaccination for Allergic Persons
- 20 March 2020 Information on the Total Replacement of AMIS
